fbpx

molecules of the month

AG-636

dihydroorotate dehydrogenase inhibitor

in Ph. I for RR-lymphoma

from opt. of literature molecule

Mol. Cancer Ther., Oct. 20, 2020

Agios Pharmaceuticals, Cambridge, MA

Structure of AG-636
1 min read

AG-636 (Agios Pharmaceuticals dihydroorotate dehydrogenase (DHODH) inhibitor clinical candidate)


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: